Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia



Status:Completed
Conditions:Schizophrenia
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 70
Updated:4/21/2016
Start Date:May 2012
End Date:March 2015

Use our guide to learn which trials are right for you!

A Randomized, Multicenter, Double-Blind, Non-inferiority Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Subjects With Schizophrenia

The purpose of this study is to demonstrate that a paliperidone palmitate 3 month
formulation (PP3M) is as effective as the paliperidone palmitate 1 month formulation (PP1M)
in the treatment of patients with schizophrenia who have been stabilized on PP1M.

This is a randomized (the study drug is assigned by chance), double blind (neither physician
nor patient knows the treatment that the patient receives), parallel group (each group of
patients will be treated at the same time), multicenter non-inferiority (the effect of the
new treatment is not worse than that of the comparison treatment) study. A new formulation
of paliperidone palmitate with a 3-month injection interval (PP3M) is being tested for use
as maintenance treatment for subjects with schizophrenia who have been first stabilized on
paliperidone palmitate with a 1-month injection interval (PP1M). The study consists of 3
phases: a screening/washout/tolerability phase (up to 21 days); a 17-week open-label (all
people know the identity of the intervention) stabilization phase (referred to as the
Open-label Phase) and a 48-week fixed dose, randomized, double-blind controlled phase
(referred to as the Double-blind Phase). After completion of the Screening Phase, all
patients will receive PP1M in the Open-label Phase. During this time, flexible dosing will
occur at Weeks 5 and 9. At Week 13 patients are to receive the dose of PP1M that was
administered at Week 9. Patients who are clinically stable at the end of the Open-label
Phase will enter the Double-blind Phase and will be randomly assigned in a 1:1 ratio to
receive fixed doses of PP3M or PP1M.

Inclusion Criteria:

- Patients with schizophrenia for more than 1 year and whose symptoms are worsening in
the opinion of the investigator

- A total score in the Positive and Negative Syndrome Scale (PANSS) between 70 and 120

- Signed informed consent

- Women must not be pregnant, breastfeeding, and if capable of pregnancy must practice
an effective method of birth control

- Men must agree to use a double-barrier method of birth control

- Be medically stable on the basis of clinical laboratory tests, physical examination,
medical history, vital signs, and electrocardiogram (ECG)

Exclusion Criteria:

- A diagnosis other than schizophrenia, e.g., dissociative disorder, bipolar disorder,
major depressive disorder, schizoaffective disorder, schizophreniform disorder,
autistic disorder, primary substance-induced psychotic disorder, dementia-related
psychosis

- Relevant history or current presence of any significant or unstable medical
condition(s) determined to be clinically significant by the Investigator (ie,
obesity, diabetes, heart disease etc)

- A diagnosis of substance dependence within 6 months before screening

- History of neuroleptic malignant syndrome (NMS) or tardive dyskinesia

- Clozapine use in the last 2 months when used for treatment-resistant or
treatment-refractory illness

- Clinically significant findings in biochemistry, hematology, ECG or urinalysis
results

- Any other disease or condition that, in the opinion of the investigator, would make
participation not in the best interest of the patient or that could prevent, limit,
or confound the protocol-specified assessments
We found this trial at
25
sites
208
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
1213
mi
from 91732
Austin, TX
Click here to add this to my saved trials
970
mi
from 91732
Bothell, WA
Click here to add this to my saved trials
2140
mi
from 91732
Bradenton, FL
Click here to add this to my saved trials
6113
mi
from 91732
Buenos Aires,
Click here to add this to my saved trials
2044
mi
from 91732
Canton, OH
Click here to add this to my saved trials
Charleston, South Carolina 29412
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
2202
mi
from 91732
Durham, NC
Click here to add this to my saved trials
?
mi
from 91732
East Lansing, MI
Click here to add this to my saved trials
13
mi
from 91732
Glendale, CA
Click here to add this to my saved trials
2443
mi
from 91732
Jamaica, NY
Click here to add this to my saved trials
2187
mi
from 91732
Kissimmee, FL
Click here to add this to my saved trials
1463
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
1586
mi
from 91732
Memphis, TN
Click here to add this to my saved trials
2492
mi
from 91732
New Britain, CT
Click here to add this to my saved trials
350
mi
from 91732
Oakland, CA
Click here to add this to my saved trials
73
mi
from 91732
Oceanside, CA
Click here to add this to my saved trials
1164
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
1572
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
1182
mi
from 91732
Wichita, KS
Click here to add this to my saved trials